arch43

EN_01453083_1302

30,00 EUR Private use
Making print for private purpose, storage in computer memory, no distribution rights.
40,00 EUR Internet - private use
Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
75,00 EUR Internet commercial use
Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
90,00 EUR Print use
Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices

caption

A general view of Pfizer Manufacturing Belgium in Puurs, Belgium, Monday, Nov. 9, 2020. Pfizer said Monday that early results from its coronavirus vaccine suggest the shots may be a surprisingly robust 90% effective at preventing COVID-19, putting the company on track to apply later this month for emergency-use approval from the Food and Drug Administration in the United States. (AP Photo/Virginia Mayo)

headline arch43

created date 2020-11-09

credit AP/Associated Press/East News

source Associated Press

byline AP

original transmission reference 20314676647969

weight 3,88MB

size 54cm x 35cm by 300dpi

keywords - Show

2020, 9, 90, A, ADMINISTRATION, AND, AP, APPLY, APPROVAL, AT, BE, BELGIUM, COMPANY, CORONAVIRUS, COVID-19, DRUG, EARLY, EFFECTIVE, EMERGENCY-USE, FOOD, FOR, FROM, GENERAL, IN, ITS, LATER, MANUFACTURING, MAY, MAYO, MONDAY, MONTH, NOV, OF, ON, PFIZER, PREVENTING, PUTTING, PUURS, RESULTS, ROBUST, SAID, SHOTS, STATES, SUGGEST, SURPRISINGLY, THAT, THE, THIS, TO, TRACK, UNITED, VACCINE, VIEW, VIRGINIA,